YANG O HUH to Combined Modality Therapy
This is a "connection" page, showing publications YANG O HUH has written about Combined Modality Therapy.
Connection Strength
0.018
-
Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm. Am J Hematol. 2017 Jun; 92(6):520-528.
Score: 0.016
-
Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol. 1990 Jun; 8(6):994-1004.
Score: 0.002